Figure 2From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancerKaplan-Meier analyses of (A) relapse free and (B) overall survival according to triple negative and non-triple negative breast cancer.Back to article page